Literature DB >> 16436307

Hepatitis vaccination among drug users.

Gianluca Quaglio1, Fabio Lugoboni, Paolo Mezzelani, Don C Des Jarlais, Alessandro Lechi.   

Abstract

Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436307     DOI: 10.1016/j.vaccine.2005.12.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Donald Calsyn; Don Alderson; Kathlene Tracy; Patrick McAuliffe; Cheryl Smith; John Rotrosen
Journal:  J Subst Abuse Treat       Date:  2011-10-27

3.  Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions.

Authors:  David C Perlman; Ashly E Jordan; Courtney McKnight; Christopher Young; Kevin L Delucchi; James L Sorensen; Don C Des Jarlais; Carmen L Masson
Journal:  J Addict Dis       Date:  2014

4.  Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial.

Authors:  Lu-Yu Hwang; Carolyn Z Grimes; Thanh Quoc Tran; April Clark; Rui Xia; Dejian Lai; Catherine Troisi; Mark Williams
Journal:  J Infect Dis       Date:  2010-10-11       Impact factor: 5.226

5.  Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users.

Authors:  Dimpy P Shah; Carolyn Z Grimes; Anh T Nguyen; Dejian Lai; Lu-Yu Hwang
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

6.  Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial.

Authors:  Yongliang Feng; Jing Shi; Linying Gao; Tian Yao; Dan Feng; Dan Luo; Zhansheng Li; Yawei Zhang; Fuzhen Wang; Fuqiang Cui; Li Li; Xiaofeng Liang; Suping Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-16       Impact factor: 3.452

7.  Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013.

Authors:  C Brouard; J Pillonel; P Sogni; A Chollet; J V Lazarus; X Pascal; F Barin; M Jauffret-Roustide
Journal:  Epidemiol Infect       Date:  2017-01-19       Impact factor: 4.434

8.  Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review.

Authors:  Fabio Lugoboni; Benedetta Pajusco; Anna Albiero; Gianluca Quaglio
Journal:  Front Psychiatry       Date:  2012-01-12       Impact factor: 4.157

9.  Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.

Authors:  Fabio Lugoboni; Raimondo Maria Pavarin; Chiara Resentera; Daniele Gambini
Journal:  Int J Environ Res Public Health       Date:  2015-04-13       Impact factor: 3.390

Review 10.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.